HIV in Latin America and the Caribbean [Lancet 2000;355:2087]: This is an editorial review in Lancet reminding those who attend the Durban International AIDS Conference that, although South African policy makers will be the focus of most attention, Latin America also deserves interest since it is "a particularly volatile mix." HIV seroprevalence ranges from 0.02% in Cuba to 12% in Haiti. Brazil spends the equivalent of $300 million/year in antiretroviral agents for 75,000 HIV-infected patients, while many countries do not offer these drugs at all or offer only a few. posted 7/3/2000